Get started
Author

Amir Warwar

ORCID: 0009-0003-5183-1111
Observed ORCID: 0009-0003-5183-1111
OpenAlex ID: A5091384716
Daratumumab and Romiplostim Combined Therapy for a Long-Standing Refractory Primary Immune Thrombocytopenia – Case Report
2025 · Ibrahim Zoubi, Amir Warwar, et al. · ImmunoTargets and Therapy · 6
PDF
Association of factor V activity with risk of venous thromboembolism and atherothrombotic cardiovascular events: A retrospective population-based cohort study
2018 · Walid Saliba, Amir Warwar, et al. · Thrombosis Research · 4
Efficacy and safety of direct oral anticoagulants in patients with venous thrombosis and inherited thrombophilia
2025 · Amir Warwar, Iren Zargari, et al. · International Journal of Medical Sciences · 3
PDF
Risk of Major Bleeding with Antiplatelet and/or Anticoagulation Therapy in Inherited Factor XI Deficiency: Insights from Real-World Observations
2024 · Shanni Vaismann, Nili Stein, et al. · Thrombosis and Haemostasis · 3
Assessing the correlation between patient and family reported outcome measures and multiple myeloma clinical parameters
2025 · Mouna Ballan-Haj, Kareem Midlej, et al. · Scientific Reports · 1
PDF
FGG p.Ser384Cys causes thrombin source-dependent underestimation of fibrinogen by Clauss assay: a familial case report
2026 · Emad Muhammad, Yarden Caspin, et al. · Thrombosis Update
PDF
The Use of Point-of-Care Hemoglobin Measurements in an Elderly Population with Hematological Disorders and Anemia
2026 · Ittai Appel, Liat Dizengoff, et al. · Hematology Reports
Recurrent hypofibrinogenemia with interleukin-6 inhibitors tocilizumab and sarilumab: A case report
2026 · Amir Warwar, Amir Haddad, et al. · Journal of Hematology and Allied Sciences
PDF
P-192: Patient reported outcome & family reported outcome and the most correlated clinical measures over one year of follow-Up
2022 · Kareem Midlig, Barbara Silverman, et al. · Clinical Lymphoma Myeloma & Leukemia
Works count: 9
Citation count: 17
H-index: 3
I10-index:
Year
Topic
Type